Article
Dr. Gary Novack: State of glaucoma pharmaceuticals, what future holds
Gary D. Novack, PhD, president of PharmaLogic Development, co-moderated an industry panel discussion on glaucoma pharmaceuticals Friday during Glaucoma 360. Watch Dr. Novack outline the state of glaucoma drug therapy and where the future is headed.
Gary D. Novack, PhD, president of PharmaLogic Development, co-moderated an industry panel discussion on glaucoma pharmaceuticals Friday during the 4th Annual Glaucoma 360 New Horizons Forum. Watch as Dr. Novack outlines the state of glaucoma drug therapy and where the future is headed.
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Related Videos
Related Content
